妊娠期梅毒:对母胎健康可预防的威胁
妊娠期梅毒是全球最常见的先天性感染,未治疗后果严重,美国先天性梅毒病例近期增加。筛查应在产前保健启动时及高危患者孕晚期两次进行,需知晓实验室所用诊断算法。妊娠期唯一推荐治疗为苄星青霉素G,青霉素过敏者应脱敏后治疗,有活力妊娠首剂应在产房持续胎心监护下给药至少24小时。
要点
- 所有孕妇应在产前保健启动时筛查梅毒,高危患者孕晚期需再筛查两次。
- 妊娠期唯一推荐治疗为苄星青霉素G,按母体感染分期给药,青霉素过敏者应脱敏后使用。
- 有活力妊娠首剂苄星青霉素G应在产房持续胎心监护下给药至少24小时,之后剂量可门诊给予。
核心结论
- 妊娠期梅毒是可预防的母胎健康威胁,识别并恰当治疗育龄女性是优先事项。
- 妊娠期唯一推荐治疗为苄星青霉素G,应按母体感染分期依据美国疾病控制与预防中心指南给药。
- 有活力妊娠首剂苄星青霉素G推荐在产房持续胎心监护下给药至少24小时。
研究设计与样本
- 原文为综述,未报告系统检索范围。
主要发现
- 梅毒可感染各孕期胎儿,超声>20周可检出,最常见为肝大和胎盘增大,也可见大脑中动脉收缩期峰值流速升高(提示胎儿贫血)、腹水和胎儿水肿。
- 超声异常妊娠在梅毒治疗期间发生胎儿窘迫及治疗失败的风险更高。
- 吉海反应可发生于高达44%的孕妇,可引起宫缩、胎心率异常,最严重者甚至死胎。
- 母体滴度下降速率与妊娠结局无关,充分治疗后应每月复查以确保滴度未升高4倍。
关键数值与推荐
- 筛查时机:产前保健启动时进行,高危患者孕晚期检查两次。
- 血清固定梅毒:既往充分治疗但非梅毒螺旋体滴度持续低(<1:8)者可出现。
- 妊娠期唯一推荐治疗为苄星青霉素G,按母体感染分期依据美国疾病控制与预防中心指南给药。
- 青霉素过敏者应脱敏后以青霉素治疗,方案与梅毒分期相适应。
- 有活力妊娠首剂苄星青霉素G应在产房持续胎心监护下给药至少24小时,其余剂量可门诊给予。
临床怎么用
- 有活力妊娠在可行时应于治疗前进行超声检查。
- 有活力妊娠首剂苄星青霉素G应在产房持续胎心监护下给药至少24小时,之后剂量可门诊给予。
- 充分治疗后母体滴度应每月复查,确保未升高4倍,以提示再感染或治疗失败。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Syphilis remains the most common congenital infection worldwide and has tremendous consequences for the mother and her developing fetus if left untreated. Recently, there has been an increase in the number of congenital syphilis cases in the United States. Thus, recognition and appropriate treatment of reproductive-age women must be a priority. Testing should be performed at initiation of prenatal care and twice during the third trimester in high-risk patients. There are 2 diagnostic algorithms available and physicians should be aware of which algorithm is utilized by their testing laboratory. Women testing positive for syphilis should undergo a history and physical exam as well as testing for other sexually transmitted infections, including HIV. Serofast syphilis can occur in patients with previous adequate treatment but persistent low nontreponemal titers (<1:8). Syphilis can infect the fetus in all stages of the disease regardless of trimester and can sometimes be detected with ultrasound >20 weeks. The most common findings include hepatomegaly and placentomegaly, but also elevated peak systolic velocity in the middle cerebral artery (indicative of fetal anemia), ascites, and hydrops fetalis. Pregnancies with ultrasound abnormalities are at higher risk of compromise during syphilotherapy as well as fetal treatment failure. Thus, we recommend a pretreatment ultrasound in viable pregnancies when feasible. The only recommended treatment during pregnancy is benzathine penicillin G and it should be administered according to maternal stage of infection per Centers for Disease Control and Prevention guidelines. Women with a penicillin allergy should be desensitized and then treated with penicillin appropriate for their stage of syphilis. The Jarisch-Herxheimer reaction occurs in up to 44% of gravidas and can cause contractions, fetal heart rate abnormalities, and even stillbirth in the most severely affected pregnancies. We recommend all viable pregnancies receive the first dose of benzathine penicillin G in a labor and delivery department under continuous fetal monitoring for at least 24 hours. Thereafter, the remaining benzathine penicillin G doses can be given in an outpatient setting. The rate of maternal titer decline is not tied to pregnancy outcomes. Therefore, after adequate syphilotherapy, maternal titers should be checked monthly to ensure they are not increasing four-fold, as this may indicate reinfection or treatment failure.
引用
- Rac MW, Revell PA, Eppes CS, et al. Syphilis during pregnancy: a preventable threat to maternal-fetal health. Am J Obstet Gynecol. 2016. PMID: 27956203. doi:10.1016/j.ajog.2016.11.1052
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。